High strength yttria-reinforced HA scaffolds fabricated via honeycomb ceramic extrusion
Abstract
The present study investigated the effects of hydroxyapatite (HA) reinforced with yttria on porous scaffolds fabricated via honeycomb ceramic extrusion. Yttria was selected as it has been demonstrated to toughen other ceramics. Moreover, yttria has been surmised to suppress dehydroxylation in HA, a characteristic that prefigures decomposition thereof during sintering into mechanically weaker phases. However, the compressive strength of yttria-reinforced hydroxyapatite (Y-HA) porous scaffolds has hitherto not been reported. Y-HA was synthesised by calcining a commercially available HA with 10wt% yttria at 1000°C. Y-HA was then fabricated into porous scaffolds using an in-house honeycomb extruder, and subsequently sintered at 1200 and 1250°C. The results were compared to the uncalcined as-received commercial powder (AR-HA) and calcined pure HA powder at 1000°C (C-HA). It was discovered that calcination alone caused marked improvements to the stoichiometry, thermal stability, porosity and compressive strength of scaffolds. The improvements were ascribed to the calcined powders with less susceptibility to both agglomeration and enhanced densification. Still, differences were observed between C-HA and Y-HA at 1250°C. The compressive strength increased from 105.9 to 127.3MPa, a larger microporosity was descried and the HA matrix in Y-HA was more stoichiometric. The latter was confirmed by XRD and EDS analyses. Therefore, it was concluded that the reinforcing of hydroxyapatite with…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.